Searched for
GLUCAGON LIKE PEPTIDE 1
Will Sensex, Nifty extend gains or turn volatile? Q1 updates, F&O expiry among 8 factors set to steer stock market this weekIndian markets head into a crucial week with investors tracking Q1 business updates, June F&O expiry, auto sales data, FII flows, crude oil...- Delhi weather today: Brace for 50°C feel-like temperature as monsoon misses date with national capitalDelhi residents brace for another hot Sunday with partly cloudy skies and strong winds, as temperatures hover around 40°C. The city experie...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...
- 'No Americans qualified': University of Michigan faces heat over $75,000 H-1B techie roles; critics question hiring of foreign workersH1-B row: The University of Michigan has sparked an online storm over H-1B visa job postings for tech roles. Independent journalist Chris B...
- Q1 earnings preview: Here’s what Nomura expects from Nestle, Titan, other consumer majors’ June quarter resultsNomura expects consumer staples to deliver a strong start to FY27, forecasting double-digit sales growth for several companies in the June ...
- Astronomers discover two of the 'puffiest' planets ever, each as big as Jupiter but lighter than cotton candyAstronomers have unveiled two colossal "super-puff" exoplanets, TOI-791 b and TOI-791 c, orbiting a distant star. These Jupiter-sized world...
- Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...
- A 1-km-wide asteroid 1997 NC1 is zooming past Earth this Saturday: Is there a risk of impact and how to watch it liveAs asteroid 1997 NC1 speeds past Earth this Saturday, many people are wondering whether our planet is in danger. The close flyby of this ma...
- Sony launches BRAVIA Theatre lineup, bets on India's growing home cinema cultureWith the rise of streaming and gaming, Indian consumers are revolutionising their living spaces into entertainment hubs. No longer content ...
- Vedanta may have a couple more tranches of promoter-driven selling; stock likely to bounce back in 1-2 weeks: Ambareesh BaligaVedanta shares saw a significant drop following a large block deal, but analysts suggest the selloff is temporary. Promoter entity Twin Sta...
- ITC bulking up with products rich in protein and fibre: Sanjiv Puri“India is also a protein-deficient market. We already have offerings such as high-protein atta, soya chunks and protein shakes, and we will...
- Fish take naps, follow sleep schedules, and may be more human than we thoughtFish sleep like humans study explained: A research reveals zebrafish exhibit complex sleep patterns, mirroring human behavior. These fish e...
- A tax-law argument could make or break Trump's H-1B $100,000 planA US court blocked a $100,000 H-1B visa fee, deeming it an unconstitutional tax imposed by presidential authority without congressional app...
- Psychology says sisters who behave like mothers are not controlling: Why some girls naturally become the second parent in the familyPsychology suggests that sisters who often behave like mothers are rarely trying to control everyone around them. More often, they are resp...
- From Monkey-faced orchid to bat flower: 7 bizarre plants that look exactly like animalsNature continues to astound with plants that uncannily mimic animals. From orchids resembling monkey faces and flying ducks to flowers that...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Indian pharma leaving generics era behind, but the Street hasn't caught up yet: Nandan KulkarniIndian pharma is shifting from generics to innovation. This transformation, extending to 2035, is creating significant new opportunities. C...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
Load More
